Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 THC
  • 1.4.3 CBD
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Biosynthesis of Cannabinoids Market Share by Application (2017-2025)
  • 1.5.2 Food Industry
  • 1.5.3 Medical Industry
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Biosynthesis of Cannabinoids Market Size
• 2.2 Biosynthesis of Cannabinoids Growth Trends by Regions
  • 2.2.1 Biosynthesis of Cannabinoids Market Size by Regions (2019-2025)
  • 2.2.2 Biosynthesis of Cannabinoids Market Share by Regions (2017-2015)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Key Players

• 3.1 Biosynthesis of Cannabinoids Revenue by Players (2018-2019)
• 3.2 Biosynthesis of Cannabinoids Key Players Head office and Area Served
• 3.3 Key Players Biosynthesis of Cannabinoids Product/Solution/Service
• 3.4 Date of Enter into Biosynthesis of Cannabinoids Market
• 3.5 Key Players Biosynthesis of Cannabinoids Funding/Investment Analysis
• 3.6 Global Key Players Biosynthesis of Cannabinoids Valuation & Market Capitalization
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Biosynthesis of Cannabinoids Market Size by Type (2017-2025)
• 4.2 Global Biosynthesis of Cannabinoids Market Size by Application (2017-2025)

5 North America

• 5.1 North America Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 5.2 Biosynthesis of Cannabinoids Key Players in North America
• 5.3 North America Biosynthesis of Cannabinoids Market Size by Type
• 5.4 North America Biosynthesis of Cannabinoids Market Size by Application

6 Europe

• 6.1 Europe Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 6.2 Biosynthesis of Cannabinoids Key Players in Europe
• 6.3 Europe Biosynthesis of Cannabinoids Market Size by Type
• 6.4 Europe Biosynthesis of Cannabinoids Market Size by Application

7 China

• 7.1 China Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 7.2 Biosynthesis of Cannabinoids Key Players in China
• 7.3 China Biosynthesis of Cannabinoids Market Size by Type
• 7.4 China Biosynthesis of Cannabinoids Market Size by Application

8 Japan

• 8.1 Japan Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 8.2 Biosynthesis of Cannabinoids Key Players in Japan
• 8.3 Japan Biosynthesis of Cannabinoids Market Size by Type
• 8.4 Japan Biosynthesis of Cannabinoids Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 9.2 Biosynthesis of Cannabinoids Key Players in Southeast Asia
• 9.3 Southeast Asia Biosynthesis of Cannabinoids Market Size by Type
• 9.4 Southeast Asia Biosynthesis of Cannabinoids Market Size by Application

10 India

• 10.1 India Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 10.2 Biosynthesis of Cannabinoids Key Players in India
• 10.3 India Biosynthesis of Cannabinoids Market Size by Type
• 10.4 India Biosynthesis of Cannabinoids Market Size by Application

11 Central & South America

• 11.1 Central & South America Biosynthesis of Cannabinoids Market Forecast (2017-2025)
• 11.2 Biosynthesis of Cannabinoids Key Players in Central & South America
• 11.3 Central & South America Biosynthesis of Cannabinoids Market Size by Type
• 11.4 Central & South America Biosynthesis of Cannabinoids Market Size by Application

12 International Players Profiles

• 12.1 Anandia Laboratories
  • 12.1.1 Anandia Laboratories Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Biosynthesis of Cannabinoids Introduction
  • 12.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.1.5 Anandia Laboratories Recent Development
• 12.2 Gingko Bioworks
  • 12.2.1 Gingko Bioworks Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Biosynthesis of Cannabinoids Introduction
  • 12.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.2.5 Gingko Bioworks Recent Development
• 12.3 Hyasynth Bio
  • 12.3.1 Hyasynth Bio Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Biosynthesis of Cannabinoids Introduction
  • 12.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.3.5 Hyasynth Bio Recent Development
• 12.4 InMed Pharmaceuticals
  • 12.4.1 InMed Pharmaceuticals Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Biosynthesis of Cannabinoids Introduction
  • 12.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.4.5 InMed Pharmaceuticals Recent Development
• 12.5 Librede
  • 12.5.1 Librede Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Biosynthesis of Cannabinoids Introduction
  • 12.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.5.5 Librede Recent Development
• 12.6 Renew Biopharma
  • 12.6.1 Renew Biopharma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Biosynthesis of Cannabinoids Introduction
  • 12.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.6.5 Renew Biopharma Recent Development
• 12.7 Cronos Group
  • 12.7.1 Cronos Group Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Biosynthesis of Cannabinoids Introduction
  • 12.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.7.5 Cronos Group Recent Development
• 12.8 Organigram
  • 12.8.1 Organigram Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Biosynthesis of Cannabinoids Introduction
  • 12.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.8.5 Organigram Recent Development
• 12.9 Teewinot Life Sciences
  • 12.9.1 Teewinot Life Sciences Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Biosynthesis of Cannabinoids Introduction
  • 12.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.9.5 Teewinot Life Sciences Recent Development
• 12.10 ICC International Cannabis Corp.
  • 12.10.1 ICC International Cannabis Corp. Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Biosynthesis of Cannabinoids Introduction
  • 12.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
  • 12.10.5 ICC International Cannabis Corp. Recent Development
• 12.11 Biotii Technologies Corp.
• 12.12 Bristol-Myers Squibb
• 12.13 Biogen Inc.
• 12.14 GW Pharmaceuticals

13 Market Dynamics

• 13.1 Drivers
• 13.2 Challenges
• 13.3 Porter’s Five Forces Analysis
• 13.4 Market Ecosystem and Value Chain Analysis

14 Key Findings in This Report

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer